111 Equity Group increases stake in Matinas Biopharma Holdings, Inc.

NEW YORK, Jan. 24, 2025 /PRNewswire/ – 111 Equity Group, LLC (“111 Equity”) and its principal filed a Schedule 13D with the Securities and Exchange Commission (“SEC”) to disclose that 111 Equity and its principal have collectively accumulated a 5.17% stock ownership stake in Matinas…